Baicalin improves metabolic dysfunction-related fatty liver disease in mice by regulating the AMPK/mTOR/SREBP-1 signaling axis
Protist
· Elsevier
Аннотация
Publication date: December 2026 Source: Journal of Radiation Research and Applied Sciences, Volume 19, Issue 4 Author(s): Bin Tang, Qifan Xiao, Mande Kang, Xin Yang, Yuqing Zhu
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Микробиология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Baicalin improves metabolic dysfunction-related fatty liver disease in mice by regulating the AMPK/mTOR/SREBP-1 signaling axis. // Protist. – URL: https://www.sciencedirect.com/science/article/pii/S1687850726006424?dgcid=rss_sd_all
Baicalin improves metabolic dysfunction-related fatty liver disease in mice by regulating the AMPK/mTOR/SREBP-1 signaling axis. Protist. https://www.sciencedirect.com/science/article/pii/S1687850726006424?dgcid=rss_sd_all
“Baicalin improves metabolic dysfunction-related fatty liver disease in mice by regulating the AMPK/mTOR/SREBP-1 signaling axis.” Protist.
@article{article10264,
title = {Baicalin improves metabolic dysfunction-related fatty liver disease in mice by regulating the AMPK/mTOR/SREBP-1 signaling axis},
journal = {Protist},
url = {https://www.sciencedirect.com/science/article/pii/S1687850726006424?dgcid=rss_sd_all}
}